C vs ISPC
Citigroup Inc. (C) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
C currently screens at market cap $214.73B and trailing P/E 15.5. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the C and ISPC stock pages for the full models.
Not investment advice.